Inventor
Qun Zhou
Inventor
Irvine, CA, US
Overview
Patents· 27 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations19%
C07KPeptides18%
A61KPreparations for medical, dental or toiletry purposes15%
C07HSugars7%
C07DHeterocyclic compounds3%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms3%
G01NInvestigating or analysing materials by determining their chemical or physical properties3%
G06FElectric digital data processing3%
G06QInformation and communication technology [ict] specially adapted for administrative, commercial, financial, managerial or supervisory purposes3%
Y02EReduction of greenhouse gas [ghg] emissions, related to energy generation, transmission or distribution3%
PatentTitleYear
10,780,095Compositions and methods for treating disorders of circadian and diurnal rhythms using prokineticin 2 agonists and antagonists202010,601,082Signal collection assembly and power battery module comprising the same202010,464,962Oligosaccharide-protein conjugates201910,439,433Adaptive power grid restoration201910,370,015Train traffic situation display system201910,214,589Site-specific antibody-drug conjugation through glycoengineering201910,064,952Glycoengineered antibody drug conjugates20189,654,544'Time-out management for session dependent applications'20179,580,511'Site-specific antibody-drug conjugation through glycoengineering'20179,494,666'NMR measurement of clinically relevant ionized biosample constituents such as ionized calcium and/or magnesium'20169,493,498'Oligosaccharide-protein conjugates'20169,475,164'Handheld power tool having a dust extractor'20168,835,614'Oligosaccharide-protein conjugates'20148,722,896'Prokineticin receptor antagonists and uses thereof'20148,101,158'Methods for treating cerebrovascular disease comprising administering an agent that inhibits prokineticin receptor activity'20128,071,336'Antibody-based therapeutics with enhanced ADCC activity'20117,700,321'Antibody-based therapeutics with enhanced ADCC activity'20107,598,048'Screening methods for identifying agents that modulate output of a circadian pacemaker'20097,323,334'Screening and therapeutic methods relating to neurogenesis'20087,259,240'Primate prokineticin receptor polypeptides'20077,177,862'Method and structure for federated web service discovery search over multiple registries with result aggregation'20077,115,560'Methods for modulating gastric secretion using prokineticin receptor antagonists'20067,114,146'System and method of dynamic service composition for business process outsourcing'20067,052,674'Prokineticin polypeptides, related compositions and methods'20065,547,845'Aqueous solution containing D.sub.1 dopamine receptor'19965,441,883'A3 adenosine receptor, DNA, and uses'19955,389,543'Cloned genes encoding the D.sub.1 dopamine receptor'1995Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1995–1996Patents assigned to UNIV DUKE (2)· patent assignee history
1995–1996Based in Portland, OR, US· patent location history
2006–2020Patents assigned to UNIV CALIFORNIA (8)· patent assignee history
2006–2017Patents assigned to IBM (3)· patent assignee history
2006–2020Based in Irvine, CA, US· patent location history
2006–2017Based in Cortlandt Manor, NY, US· patent location history
2010–2019Patents assigned to GENZYME CORP (8)· patent assignee history
2010–2019Based in Ashland, MA, US· patent location history
2011–2019Patents assigned to ZHOU QUN (6)· patent assignee history
2020Based in Shenzhen, CN· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| GENZYME CORP | 8 | 2010–2019 |
| UNIV CALIFORNIA | 8 | 2006–2020 |
| ZHOU QUNself | 6 | 2011–2019 |
| IBM | 3 | 2006–2017 |
| UNIV DUKE | 2 | 1995–1996 |
Locations
| Location | Patents | Span |
|---|---|---|
| Irvine, California, US | 8 | 2006–2020 |
| Ashland, Massachusetts, US | 8 | 2010–2019 |
| Portland, OR, US | 3 | 1995–1996 |
| Cortlandt Manor, New York, US | 2 | 2006–2017 |
| Shenzhen, CN | 1 | 2020 |